New Results
Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic
Sarel Cohen, Moshik Hershcovitch, Martin Taraz, Otto Kißig, View ORCID ProfileDavis Issac, Andrew Wood, Daniel Waddington, Peter Chin, Tobias Friedrich
doi: https://doi.org/10.1101/2022.03.24.485618
Sarel Cohen
1Hasso Plattner Institute, University Potsdam, Germany
Moshik Hershcovitch
2IBM Research
Martin Taraz
1Hasso Plattner Institute, University Potsdam, Germany
Otto Kißig
1Hasso Plattner Institute, University Potsdam, Germany
Davis Issac
1Hasso Plattner Institute, University Potsdam, Germany
Andrew Wood
3Boston University
Daniel Waddington
2IBM Research
Peter Chin
3Boston University
Tobias Friedrich
1Hasso Plattner Institute, University Potsdam, Germany
Article usage
Posted March 24, 2022.
Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic
Sarel Cohen, Moshik Hershcovitch, Martin Taraz, Otto Kißig, Davis Issac, Andrew Wood, Daniel Waddington, Peter Chin, Tobias Friedrich
bioRxiv 2022.03.24.485618; doi: https://doi.org/10.1101/2022.03.24.485618
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8722)
- Bioinformatics (29127)
- Biophysics (14932)
- Cancer Biology (12048)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12220)
- Genomics (16766)
- Immunology (11841)
- Microbiology (28005)
- Molecular Biology (11552)
- Neuroscience (60808)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4939)
- Plant Biology (10384)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)